Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy

Genetic testing for hypertrophic cardiomyopathy has been commercially available for almost a decade; however, low mutation detection rate and cost have hindered uptake. This study sought to identify clinical variables that can predict probands with hypertrophic cardiomyopathy in whom a pathogenic mutation will be identified.Probands attending specialized cardiac genetic clinics across Australia over a 10-year period (2002-2011), who met clinical...